Share This

Saturday, January 23, 2021

A look back at Trump's four years, US trumped out in trade war


A look back at Trump’s four years 

https://youtu.be/2BdEO3hKt60 
 

With the new President in the White House, the time to embrace the global community is now and not delay any longer. Washington will then be looked upon with great respect after four years of rule by one man, which was nothing but traumatic, chaotic and deceitful.( Pic shows Biden signing executive orders on first day of Presidency.)


AS we now welcome the era of Bidenomics over the next four years, one cannot help but to review the impact of the previous US president’s tenure which ended just three days ago.

One of Trump’s rallying cry was his call of making America great again. With that, the US embarked on a trade war with the rest of the world, in particular with China, to reduce the massive trade deficits that the US has been experiencing for umpteen years.

In addition, Trump also wanted to bring foreign manufacturers to the US on the assumption that this would reduce their import bill, attracting foreign direct investments as well as creating jobs for Americans.

The trade war saw US imposing tariffs on Chinese goods, and in retaliation, China too started to impose tariffs on US goods – effectively a tit-for-tat move by the two superpowers where effectively nobody wins.

The US-China trade war led to nervousness in markets, in particular during the 2018-2019 period, but the impact of the stand-off tapered off sometime about a year ago when both agreed to enter into the Phase 1 trade deal.

To recap, that trade truce entailed China agreeing to increase the import of American goods and services by at least US$200bil over the next two years. China, which purchased some US$130bil in total goods and US$56bil in services in 2017, was supposed to increase total imports by about US$162bil in total goods purchased and US$38bil in services over the two-year period.

In terms of breakdown for the year 2020 and 2021, China was to increase its imported goods by US$64bil in 2020 and US$98bil this year from the base line figure of 2017. In terms of services, the level of imports by China was expected to increase by about US$13bil last year and US$25bil this year.

Since the Phase 1 trade deal was inked about a year ago, how has the Chinese trade with the rest of the world and in particular the US performed in 2020? Overall, with the December 2020 trade data just released last week, China saw its total exports for the year rising by 3.6% while imports fell by 1.1% year-on-year (y-o-y).

This, of course, would lead to one thing – a widening trade surplus. In fact, China’s 2020 total trade surplus jumped by 27% to US$535bil – the highest in five years.

How about China’s trade with the US? Based on the data released, China’s trade surplus with the US rose by 7.1% to US$316.9bil and contrary to what president Trump intended to achieve with his tariff measures. Chinese exports to the US in 2020 increased by 7.9% to US$451.8bil while imports surged 9.8% y-o-y to US$134.9bil.

This definitely fell short of the targeted US$194bil total goods that was supposed to be imported by China in 2020 (US$130bil base line + US$64bil target). In terms of percentage, the shortfall was as much as 30%.

Based on the data from the US, trade with China up to November 2020 showed that US exports to China totalled some US$110bil while imports stood at US$393.6bil, giving rise to a trade deficit of US$283.6bil.

It is likely that for the month of December 2020, the US will add another US$30bil in deficit and thus bringing the 2020 total trade deficit with China to around US$314bil. Total exports for the year will likely come in at about US$125bil, up 15.8% y-o-y; while imports are expected to come in 3% lower at US$439bil.

Compared with the 2018 import value, US imports from China effectively would have dropped by about US$102bil but exports to China have increased by just 2.5% from the 2018 level of US$122bil.

In essence, while the US bought 19% less goods from China, what it sold to Beijing was barely any higher. In addition, while the US trade deficit with China may have improved by about US$30bil y-o-y in 2020, the Chinese trade surplus with the rest of the world is significantly higher.

What does this mean for Phase 1 Trade Deal?

With a shortfall of some US$70bil (based on US data) in 2020 and on the assumption that China is to import an additional amount of US$98bil this year to meet the target of Phase 1 trade deal, China would need to import as much as US$298bil worth of goods from the US this year!

This is derived after taking into consideration the base line of US$130bil in 2017, adding the US$70bil shortfall in 2020 and topping it up with the pledged US$98bil increase. Indeed, it is highly unlikely that China would be able to meet this target, which is more than doubled what it imported from the US last year.

Effectively, Phase 1 trade deal is dead in the water. Trump’s strategy can be said to have failed and China in effect has emerged as a clear winner in the trade war. What is now left to be seen is what will Bidenomics bring to the table as far as the trade war is concerned.

Will the new President soften his approach towards China? Will it be status quo or will Biden continue with Trump’s hard approach in dealing with China? After all, Janet Yellen, the treasury secretary nominee was quoted as saying that the US is prepared to take on China’s “abusive” trade and economic practices.

However, in the interest of globalisation and ease of movement of goods and services, tariffs effectively serve no purpose, especially to consumers as it actually only adds to the cost of goods purchased as the cost of tariff is passed on to the end buyers. Tariff is not a tool to restrict movement of goods or services. Instead, nations should strive to make themselves more competitive.

With the new President in the White House, the time to embrace the global community is now and not delay any longer. Washington will then be looked upon with great respect after four years of rule by one man, which was nothing but traumatic, chaotic and deceitful.

By Pankaj C. Kumar who is a long-time investment analyst. Views expressed here are the writer’s own.

 Source link

 

 Related posts:

 

Trapped in US-China trade war when 2 elephantine economices fight ...

 

US-China trade war escalates, tariff list aims to hinder China’s high-tech development: expert

 

China hits back after US imposes tariffs worth $34bn

 

China staunch defender of free trade under WTO, meet the 'selfish giant' of global trade

 

Did Huawei violate Iran sanctions? No, it shows deeper US-China battle for global influence as power coming from high-tech sector 

 

Minds without borders: A coffee with Huawei Ren: We will be reborn by 2021

 

China battles US for AI and robotic space: Who’s ahead?

 
 

 

US adopts blinkered view of TikTok

Thursday, January 21, 2021

Joe Biden sworn in as 46th US president, orders US to rejoin climate change, drops Trump's toxic rhetoric toward China, but 'courage needed to fix ties ...'

 


https://youtu.be/WBn0yKPLJK8

Joe Biden sworn in as 46th US president 

 

President Biden orders US to rejoin Paris Agreement on climate change

US President Joe Biden on Wednesday signed an executive order returning the United States to the 2015 Paris Agreement on climate change.

 

 Biden drops Trump's toxic rhetoric toward China, but 'courage needed to fix ties'

After a series of drastic events that laid bare the profound weaknesses and failures of the US system, Joe Biden was officially sworn in as the 46th President of the US during a relatively empty event heavily guarded by thousands of soldiers with weapons of war, and used his inaugural speech to address domestic challenges in stark contrast to Donald Trump's bellicose and at times borderline racist rhetoric against China during his farewell speech.

 

As Joe Biden is about to be inaugurated as the new US president in Washington, DC, on Wednesday, .

 

 

Harris Sworn in as 49th US Vice president



Live: Donald Trump holds sendoff ceremony before Joe Biden's inauguration




https://youtu.be/MgWb0HZ10HY


 Related post:

Wednesday, January 20, 2021

Vaccine distribution shouldn’t lead to catastrophic moral failure

 

Inactivated COVID-19 vaccine CoronaVac produced by Chinese vaccine developer Sinovac Photo: Courtesy of Sinovac

 

Chinese vaccines gaining momentum overseas




https://youtu.be/WV2v8osGAa4

WHO chief blasts rich countries for hoarding vaccines



https://youtu.be/2SFm_lc_r0k


WHO Director-General Tedros Adhanom Ghebreyesus on Monday lashed out at inequitable distribution of COVID-19 vaccines. He said most of the vaccines "have now been administered" in rich countries. "The world is on the brink of a catastrophic moral failure - and the price of this failure will be paid with lives and livelihoods in the world's poorest countries," he warned.

For now, seven COVID-19 vaccine candidates have been administered worldwide, the key of which are the US-developed and China-developed ones. The US-made vaccines have basically flowed to developed countries, while the China ones have mainly gone to developing countries.

Among rich countries that use US vaccines, the US has vaccinated 12 million people, ranking the first. 4.31 million doses (including the Oxford-AstraZeneca vaccine) have been administered in the UK, topping European countries. Canada reportedly has ordered enough vaccine doses to protect each Canadian five times. Three members of the Five Eyes alliance have left others way behind them in vaccine distribution. They have prioritized their own demands amid short vaccine supply, though Britain claimed it raised donations to help vulnerable countries access COVID-19 vaccines.

The US, the UK and Canada all shout loudly for developing countries' human rights. But they are the ones contributing to "a catastrophic moral failure" that Ghebreyesus said. When the interests of their own countries are not involved, they express concerns about human rights of other countries. But when they need to take real actions to help other countries realize human rights, they retract their heads as turtles.

Vaccines developed by Chinese companies have become a key resource to break rich countries' privilege and safeguard developing countries' rights. Chinese vaccines are cheap, easy to be transported and used all over the world. Besides, China has an explosive vaccine production capability and it has a greater surplus to provide the outside world, since the domestic epidemic in China has been relatively alleviated.

At the initial stage of distribution when supply is short, US vaccines will inevitably go to developed countries. The Five Eyes countries know this well. According to the WHO, it took over 10 years for life-saving HIV/AIDS drugs to reach poor countries after its invention. When the poor countries could put the HINI vaccines into use, the epidemic had already been over. Based on the vaccine distribution order in the past, developing countries will undergo many delays and setbacks to get US COVID-19 vaccines.

The Chinese vaccines are an important humanitarian supplement, but the US and its major allies have taken a cold attitude and even disparaged Chinese vaccines. They didn't offer much help in Chinese vaccines' Phase III trials. Particularly, Western public opinion in general is not friendly. It is keen on hyping and exaggerating any information unfavorable to Chinese vaccines and accuses China of engaging in "vaccine diplomacy."

This has formed a sharp contrast with the fact that Western public opinion influencers are flattering Pfizer vaccines and downplaying news the vaccines caused deaths.

This represents vaccine nationalism and egoism that disregards the urgent humanitarian demands, giving rise to an atmosphere in which political prejudice dominates the pandemic fight. Unity is lacking in the fight against the virus, mainly because of the negative attitudes of the US and its major allies.

On the other hand, the top leaders in several countries such as Indonesia, Turkey, Seychelles, Serbia and the Philippines have strongly backed Chinese vaccines. Some even publicly got vaccinated with Chinese vaccines. This has had a positive impact on the confidence of developing countries with Chinese vaccines. They are safeguarding the rights of developing countries to get vaccinated simultaneously with developed countries and they are bravely pursuing fairness.

US and Chinese vaccines have their own advantages. They are supposed to cooperate with each other closely to fight the novel coronavirus. Besides prices and logistical factors, their usage in developed and developing countries should not be affected by politics. Don't let the "catastrophic moral failure" become reality and consolidated. It must be stressed that the coronavirus is the common foe of humanity, and the battlefield and tools that fight against it cannot be separated.

Source link

 

RELATED ARTICLES
 

 Related posts:

Getting ready for Covid-19 vaccines

 The dreadful year is coming to an end with optimism and hope in the air as we greet 2021.

 

China makes steady progress towards coronavirus vaccines to market 

 

China's Covid-19 vaccine will be available for all, could be ready for public use early next year

China will make its Covid-19 vaccine a global public good when it is ready for application after successful research and clinical trials, a senior Chinese official said.

 

 Inject awareness’ of how Covid-19 vaccine works 

 

China joins WHO-backed vaccine programme Covax rejected by Trump